13F
← All fund report cards

Calamos Advisors LLC

13F equity value
$25.9B
Positions
1,144
Top 10 concentration
27.3%
Quarters / total new picks
32 / 1,261
13F equity value over time
$0M$13B$26B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 1.51, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+2.2%
t-stat
1.51
Quarterly win rate
53%
Annualized excess
+1.1%
$1 → follow vs universe
$2.26 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00720180630: follow 0.97120180930: follow 1.00920181231: follow 0.94920190331: follow 0.97820190630: follow 1.00020190930: follow 1.07620191231: follow 0.93120200331: follow 1.18520200630: follow 1.36120200930: follow 1.91520201231: follow 1.77320210331: follow 1.82920210630: follow 2.04520210930: follow 1.66920211231: follow 1.33020220331: follow 1.42920220630: follow 1.36920220930: follow 1.41920221231: follow 1.35220230331: follow 1.40520230630: follow 1.32320230930: follow 1.50020231231: follow 1.48120240331: follow 1.48220240630: follow 1.69620240930: follow 1.72020241231: follow 1.64420250331: follow 1.80620250630: follow 1.83720250930: follow 2.03620251231: follow 2.263 0.84 1.64 2.44 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1144 · 2026 Q1

Ticker Value Weight QoQ
NVDA $1.4B
5.5%
ADD
AAPL $1.2B
4.7%
ADD
MSFT $879M
3.4%
ADD
GOOGL $736M
2.8%
ADD
AMZN $709M
2.7%
ADD
AVGO $511M
2.0%
ADD
SPY $459M
1.8%
ADD
META $418M
1.6%
ADD
WDC $399M
1.5%
TRIM
TSLA $313M
1.2%
ADD
GOOG $287M
1.1%
ADD
LLY $284M
1.1%
ADD
BABA $262M
1.0%
HOLD
JPM $237M
0.9%
ADD
V $230M
0.9%
ADD
XOM $218M
0.8%
ADD
WMT $195M
0.8%
ADD
JNJ $189M
0.7%
ADD
BA $186M
0.7%
TRIM
ORCL $184M
0.7%
NEW

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.